DI LORENZO, GIUSEPPE
 Distribuzione geografica
Continente #
AS - Asia 243
EU - Europa 185
NA - Nord America 161
SA - Sud America 47
AF - Africa 7
Totale 643
Nazione #
US - Stati Uniti d'America 147
SG - Singapore 142
RU - Federazione Russa 114
CN - Cina 54
BR - Brasile 38
HK - Hong Kong 23
IT - Italia 22
DE - Germania 18
VN - Vietnam 17
CA - Canada 9
NL - Olanda 8
AR - Argentina 7
FI - Finlandia 7
GB - Regno Unito 7
MX - Messico 5
CI - Costa d'Avorio 3
UA - Ucraina 3
ZA - Sudafrica 3
BD - Bangladesh 2
FR - Francia 2
IE - Irlanda 2
AZ - Azerbaigian 1
CO - Colombia 1
IL - Israele 1
MD - Moldavia 1
NP - Nepal 1
PE - Perù 1
PK - Pakistan 1
PL - Polonia 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 643
Città #
Singapore 81
Moscow 37
Hong Kong 23
Beijing 17
Ashburn 16
Millbury 12
Ho Chi Minh City 10
Munich 9
Amsterdam 8
Naples 8
Los Angeles 7
Princeton 7
Chandler 6
Jacksonville 6
Nanjing 6
New York 5
Santa Clara 5
Montreal 4
Ottawa 4
Phoenix 4
São Paulo 4
Buffalo 3
Buenos Aires 2
Charlotte 2
Denver 2
Hangzhou 2
Hanoi 2
Lanzhou 2
London 2
Mexico City 2
Nanchang 2
Napoli 2
Pontedera 2
Poplar 2
Redondo Beach 2
Rio de Janeiro 2
Shenyang 2
Ubá 2
Ananindeua 1
Aparecida de Goiânia 1
Arezzo 1
Baku 1
Baoding 1
Barretos 1
Bismarck 1
Biên Hòa 1
Bovril 1
Brasília 1
Bucaramanga 1
Bình Dương 1
Cajazeiras 1
Carney 1
Changsha 1
Chicago 1
Crato 1
Călăraşi 1
Da Nang 1
Des Moines 1
Eboli 1
Extrema 1
Falkenstein 1
Falls Church 1
Fortaleza 1
Francisco Morato 1
Giv‘at Shmuel 1
Goiânia 1
Hebei 1
Hefei 1
Hortolândia 1
Houston 1
Humberto de Campos 1
Ibirité 1
Ibiúna 1
Ituiutaba 1
Itumbiara 1
Iturama 1
Ituzaingó 1
Jiaxing 1
Johannesburg 1
Johnston 1
José C. Paz 1
Juiz de Fora 1
Kunming 1
Lima 1
Lubny 1
Maresias 1
Mercês 1
Mirassol 1
Muriaé 1
Norwalk 1
Orem 1
Planaltina do Paraná 1
Poncitlán 1
Quận Bình Thạnh 1
Resende 1
Rome 1
Rosario 1
San Miguel 1
Santa Cruz do Capibaribe 1
Santana de Parnaíba 1
Totale 376
Nome #
Neuroendocrine differentiation after neoadjuvant hormonal treatment in prostate cancer. 131
Is there a standard chemotherapeutic regimen for hormone-refractory prostate cancer? Present and future approaches in the management of the disease. 90
Pegylated liposomal doxorubicin as second-line therapy in the treatment of patients with advanced classic Kaposi sarcoma: a retrospective study. 78
Involvement of growth factor receptors of the epidermal growth factor receptor family in prostate cancer development and progression to androgen independence. 75
The need to reduce patient discomfort during transrectal ultrasonography-guided prostate biopsy: what do we know? 75
Pegylated liposomal doxorubicin in stage IVB mycosis fungoides. 71
Docetaxel Rechallenge in Castration-Resistant Prostate Cancer: Scientific Legitimacy of Common Clinical Practice. 64
Nefrectomia citoriduttiva e palliativa 63
Totale 647
Categoria #
all - tutte 2.286
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.286


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 4 0 0 0 0 0 0
2021/202228 0 0 0 0 0 0 0 0 3 2 4 19
2022/202332 8 2 1 0 1 3 0 3 3 9 2 0
2023/202452 0 13 10 8 1 0 1 3 0 2 9 5
2024/2025216 10 8 0 1 5 7 21 14 11 17 101 21
2025/2026262 50 27 51 54 80 0 0 0 0 0 0 0
Totale 647